Product Overview
British Dragon Mesterolone Tablets contain 25 mg of mesterolone, the compound the market knows as Proviron. It is a DHT-derived oral androgen with a lopsided profile: strong androgenic activity and very little anabolic effect, which is why it is never bought as a growth drug. What it does instead is change the hormonal environment around other compounds.
The mechanism that sells it is sex hormone binding globulin. Mesterolone binds SHBG with high affinity, which frees up more testosterone to circulate unbound, and unbound testosterone is the fraction that reaches receptors. Users who add it to a cycle report a rise in libido and a harder, denser look without any of the fluid that comes from an aromatizing drug. It does not convert to estrogen, so gynecomastia and water retention are outside its profile entirely.
Its structural quirk is worth stating plainly: mesterolone has no 17-alpha-alkyl group, and that is rare for a steroid that is taken by mouth. The missing modification is the reason its hepatic load is rated low rather than high. In practice it is used as a supporting player alongside a base compound - for instance with Testabol Propionate or Mastabol 100 - rather than as the backbone of a plan.
Medical use is a different setting from the gym, and the reference record for this molecule is built on it: the indications listed are low testosterone and hypogonadism in men, where replacement dosing runs 25 mg two to three times a day. Detection belongs on the same sheet, because urinary metabolites stay visible for 10 to 14 days and longer as dose and duration rise. The structure is a 1-alpha-methylated form of DHT, which is the detail that separates it from the injectable DHT-derived compounds.
Dosage Protocol
Mesterolone is taken in divided doses because the half-life sits at 12 to 13 hours and one tablet does not cover a full day. Replacement dosing in a medical setting is 25 mg two to three times a day; the sports ranges below start lower.
| Beginner | 25 mg a day, taken for as long as the base cycle runs |
| Intermediate | 50 mg a day, taken as two doses |
| Advanced | 50-100 mg a day, the outer limit in the material reviewed |
| Female | Not recommended: the androgenic effect is strong and the virilization risk is high, so no female protocol is given |
| Administration | Oral tablets in divided doses, taken alongside another compound because the benefit comes from SHBG binding rather than from the drug alone |
Suggested Protocols
This is an add-on. The three layouts below show where it is usually placed, and in each case a different compound carries the anabolic work.
What to Expect
- Androgenic tone. Libido and a denser look appear in the first one to two weeks at 50 mg a day.
- Free testosterone. Circulating unbound testosterone can rise because the drug occupies SHBG and leaves more hormone available.
- No fluid, no breast effects. Without aromatization there is nothing to hold water and no estrogenic tissue response to watch.
- Virilization signs. Acne, hair shedding and voice changes are the things to watch, and they matter most for women.
- Realistic scope. The anabolic effect is small. Anyone expecting this to add size on its own will be disappointed.
- Not a base. It does not replace testosterone, and it does not restart the axis of a suppressed cycle.
- Limitation. Its value is what it does to the other compounds in the stack, not what it does alone.
Side Effects and Management
The list is androgenic almost from top to bottom, with a lipid item and a mild suppression item at the end.
Post-Cycle Therapy and Recovery
Two points matter here. Mesterolone is not a recovery drug, and it is not a cycle base either; whatever plan is needed after a course belongs to the compounds that suppressed the axis in the first place.
